Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 392 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07503301Enrolling by invitation
Study on stroke recovery and limb therapy
This trial tests if a limb therapy called RIC can help people recover from a stroke caused by small vessel disease. It is designed for people aged 50-65 who have had a recent stroke and have few other health issues.
Hangzhou, ZhejiangAges 50–65 - NCT07497867Recruiting
Long-term study of Korean CADASIL patients
This study follows people with CADASIL over time to learn more about the condition. It may help researchers understand how CADASIL progresses and improve care for patients.
Jeju City, Jeju-doAges 19 years+ - NCT05786131Recruiting
Stent treatment: fix all blocked arteries vs culprit only
This trial compares two ways of doing a stent procedure in people who had an NSTEMI heart attack: fixing all significant blockages versus fixing only the “culprit” blockage. It may help find which approach is safer and more effective for preventing complications.
GrazAges 18 years+ - NCT04576130Recruiting
ICD study after cardiac arrest from an abnormal heart rhythm
This study looks at an implantable defibrillator (ICD) strategy in people who survived a cardiac arrest caused by an abnormal rhythm (ventricular fibrillation or ventricular tachycardia). It aims to reduce the risk of another dangerous rhythm after the blocked heart arteries are fully treated.
CopenhagenAges 18 years+ - NCT06792643RecruitingPhase 2
Cangrelor for heart attack patients on heart-lung support
This trial tests whether adding a fast-acting anti-clotting drug (cangrelor) helps people having a massive heart attack who need a heart-lung machine (VA-ECMO). The goal is to see if it reduces clotting risks without causing dangerous bleeding.
Milan, ItalyAges 18 years+ - NCT05866874Recruiting
Watching heart warning signs after non-heart surgery
This study checks whether close monitoring of vital signs around the time of non-cardiac surgery can help identify small heart injuries (called perioperative myocardial infarction or injury). It may help doctors spot people at higher risk sooner, especially after certain major surgeries.
Basel, Canton of Basel-CityAges 40–85 - NCT06374667Recruiting
Skull bone injection vs. IV for large stroke
This trial tests a new way to give medicine for a large stroke on one side of the brain. The medicine is injected into the skull bone instead of through a vein, and researchers want to see if it works better and is safe.
Wuhu, AnhuiAges 18–80 - NCT05416385Recruiting
Stress echo scan with special contrast to study carotid plaque
This study uses a heart stress ultrasound test, plus a contrast dye, to look for new blood vessel growth inside carotid plaque (the buildup in neck arteries). It may help doctors better judge the risk of stroke and determine which people need closer care.
Calgary, AlbertaAges 18 years+ - NCT07400458Recruiting
Long-term study after Hearticellgram-AMI for heart attack patients
This study checks on people who have already received a treatment called Hearticellgram-AMI for heart attack. It wants to see how they are doing over the long term.
Seoul, GangnamAges Any age - NCT07402642Recruiting
Early Education to Lower Heart Attack Risk Factors
This trial tests if personalized education after a heart attack helps patients lower their future risk of heart problems. It focuses on people who had an emergency procedure to open blocked arteries.
Las Palmas de Gran Canaria, Las PalmasAges 18 years+ - NCT06443008Recruiting
Biofeedback training for arm function after stroke
This study tests whether a special feedback device that detects muscle signals can help improve arm and hand movement after a stroke. It is designed for people aged 65 and older.
Yiwu, ZhejiangAges 65–80 - NCT06535503Recruiting
Heart attack with shock: Study of patient outcomes in Abu Dhabi
This study looks at the medical records of people who had a severe heart attack (STEMI) that caused cardiogenic shock. Researchers want to understand how these patients did during their hospital stay to improve care in the future.
Abu Dhabi, Abu Dhabi EmirateAges 18 years+ - NCT06101862Recruiting
CT scan vs. angiogram for certain heart attacks
This trial compares two ways to look at heart arteries: a CT scan (noninvasive) versus a traditional angiogram (a tube put into an artery). The goal is to see which is better for people having a certain type of heart attack.
Copenhagen, HellerupAges Any age - NCT07382700Enrolling by invitation
Blood markers in heart attack patients treated with stents
This study looks at certain fats in the blood of people having a severe heart attack called STEMI. Researchers want to see if these fats can help understand what happens in the body during a heart attack.
Ningbo, ZhejiangAges 50–70 - NCT07380919RecruitingPhase 2/Phase 3
Study of ranolazine to prevent heart muscle damage after a heart attack
This trial tests whether a medication called ranolazine can help prevent damage to tiny blood vessels in the heart after a certain type of heart attack (STEMI). You may be eligible if you recently had this kind of heart attack and had a successful procedure to open a blocked artery, but still have other blockages that can be treated with stents.
Catanzaro, ItalyAges 18–80 - NCT07381803RecruitingPhase 3
Fexofenadine for heart attack recovery
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
Hangzhou, ZhejiangAges 18 years+ - NCT07379190RecruitingPhase 3
Tirofiban for late window stroke due to artery plaque
This trial tests whether a drug called tirofiban can help people who had a stroke more than 24 hours ago but within 7 days. It is for strokes caused by a buildup of plaque in a large brain artery, and uses a special MRI to confirm the cause.
Weifang, China/Shandong ProvinceAges 18 years+ - NCT06662890Recruiting
Heart attack blood oxygen therapy trial
This trial tests if giving extra oxygen to the blood during a heart attack can help heart muscle recover. It is for people having a specific type of heart attack and balloon treatment.
Clydebank, DunbartonshireAges 18 years+ - NCT07361783Recruiting
Heparin before hospital for heart attack
This trial tests whether giving a blood thinner (heparin) early, before you get to the hospital for a heart attack procedure, can improve outcomes. It is for people having a specific type of heart attack (STEMI) who will receive a balloon angioplasty within 2 hours.
Wuhan, HubeiAges 18 years+ - NCT07354399Recruiting
Strength and cardio training for women with heart disease
This study looks at whether adding strength training to aerobic exercise helps women with coronary artery disease improve their fitness and build muscle. It may help you recover better after a heart event.
LjubljanaAges 18 years+ - NCT07354646Recruiting
Understanding heart disease with T1 mapping MRI
This study uses a special type of MRI (T1 mapping) to better understand different heart conditions. It may help doctors improve diagnosis and treatment by looking at detailed images of your heart muscle.
Beijing, Beijing MunicipalityAges Any age - NCT07353424Recruiting
Salicornia extract for memory after a small stroke
This study tests whether a polyphenol-rich extract from a salt-tolerant plant called Salicornia can slow memory decline in people who have had a lacunar stroke. It compares the extract to the usual care you would receive.
SevilleAges 40–90 - NCT06857838Recruiting
Bypass surgery for symptomatic myocardial bridge
This trial tests whether bypass surgery is effective for people with a myocardial bridge (a heart muscle that arches over an artery) that still causes symptoms despite medication. It aims to see if surgery can improve symptoms and outcomes.
Xi'an, ShaanxiAges 18–80 - NCT07351825Recruiting
Heart MRI study for people with ischemic heart disease
This study uses heart MRI scans to find markers that predict outcomes in people with ischemic heart disease, including those who have had a heart attack. It may help doctors better understand your condition and guide future care.
Beijing, Beijing MunicipalityAges Any age
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 392 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.